For half a century, the “gold standard” of labor safety has been a single, flickering line on a screen. But as recent reporting confirms, that line is often a lie. Our obsession with isolated fetal heart rate patterns has created a surgical “false positive pipeline,” driving C-section rates to historic highs without actually reducing the incidence of cerebral palsy.
The myth of the “failed” test
The skepticism surrounding EFM often stems from large-scale studies like the INFANT trial, which concluded that computerized monitoring did not improve outcomes. However, a closer look reveals a critical flaw: Those studies did not test the potential of the technology; they tested a stagnant model of “pattern recognition” that has not fundamentally changed since the 1970s.
Imagine trying to diagnose a complex heart condition using a 1920s-era EKG. The signal is there, but the lens is too blurred to see it. We have been judging EFM’s success by its ability to predict a baby’s umbilical cord pH in the final minutes of labor, a “fire alarm” that tells us the house is burning only after the fire is irreversible.
We now know that roughly 35 percent of cerebral palsy cases have genetic origins that no monitor could ever prevent.
Inside the “trashcan” of Category II
Today, clinical guidelines group fetal heart patterns into three buckets. Category I is “safe,” and Category III is a “crash” emergency. The vast majority of American births, however, fall into Category II, the medical “trashcan” of uncertainty.
In our current litigious climate, Category II is where medical judgment goes to die. Because the signals are ambiguous and doctors are terrified of “nuclear” malpractice verdicts, this uncertainty triggers unnecessary C-sections. It is a defensive crouch that protects the clinician’s legal record at the expense of the mother’s physical recovery.
An ocean of meanings
While the American clinical system remains stuck in a cycle of defensive medicine, a global scientific awakening is occurring. Our research, and that of colleagues in Canada, the UK, France, Italy, Germany, Australia, and New Zealand, has shown that there is an “ocean of meanings” hidden within the fetal heart rate.
We can now look past the simple “ups and downs” to fetal heart rate variability (fHRV), the subtle, beat-to-beat changes controlled by the autonomic nervous system. By using advanced signal processing and artificial intelligence (AI), we can track a fetus’s health trajectory in real time. We can detect the earliest signs of fetal inflammatory response and cardiovascular decompensation long before a baby reaches the point of distress.
Instead of a binary “yes or no” to surgery, these tools provide a multidimensional view of a baby’s “physiological reserve.” This allows us to move from rescue to prevention. We can see a baby beginning to struggle and intervene early, perhaps simply by changing the mother’s position or adjusting medication, effectively moving the labor from the “trashcan” of Category II back to safety.
The way forward
True progress requires moving away from late-stage rescue and toward early, holistic prevention. This entails two parallel, complementary evolutions. First, we must leverage AI to detect computerized heart rate variability that the human eye cannot see and to extract the rich predictive information encoded in it. Second, we must adopt the Fetal Reserve Index (FRI).
The FRI acknowledges that the fetus is not a heart rate in a vacuum; it is half of a dyad. By quantifying the fetus’s “reserve” through eight distinct markers, including maternal BMI, advanced age, and uterine activity, we can detect when a baby is truly losing the ability to compensate for the stress of labor.
When we ignore these clinical contexts, we do not just increase surgery rates; we disrupt the biological integrity of birth, impacting the infant’s microbiome and long-term health. We do not need fewer monitors; we need more intelligent ones. By aligning high-precision tech with maternal-fetal physiology, we can finally move from defensive medicine to a data-driven model that truly protects both mother and child.
Martin G. Frasch is a research affiliate. Mark I. Evans is an obstetrician-gynecologist. Philip J. Steer is an emeritus professor of obstetrics-gynecology.
